United States · Bill · HR
H.R. 4385 (117th)
Cancer Drug Parity Act of 2021
Introduced
9 July 2021
Last action
9 July 2021 · Introduced
Status
Referred to the House Committee on Education and Labor.
Sponsors
Rep. Higgins, Brian [D-NY-26], Rep. Guthrie, Brett [R-KY-2], Rep. Matsui, Doris O. [D-CA-7], Rep. Bilirakis, Gus M. [R-FL-12], Rep. Morelle, Joseph D. [D-NY-25], Rep. Grothman, Glenn [R-WI-6], Rep. Case, Ed [D-HI-1], Rep. Wild, Susan [D-PA-7], Rep. McBath, Lucy [D-GA-6], Rep. Clarke, Yvette D. [D-NY-9], Rep. Panetta, Jimmy [D-CA-19], Rep. Maloney, Carolyn B. [D-NY-12], Rep. Bonamici, Suzanne [D-OR-1], Rep. Blumenauer, Earl [D-OR-3], Rep. Suozzi, Thomas R. [D-NY-3], Rep. Brownley, Julia [D-CA-26], Rep. Trone, David J. [D-MD-6], Rep. Young, Don [R-AK-At Large], Rep. Connolly, Gerald E. [D-VA-11], Rep. Pingree, Chellie [D-ME-1], Rep. Yarmuth, John A. [D-KY-3], Rep. Fitzpatrick, Brian K. [R-PA-1], Rep. Davis, Rodney [R-IL-13], Colin Allred, Rep. Wittman, Robert J. [R-VA-1], Rep. Bost, Mike [R-IL-12], Rep. Barragán, Nanette Diaz [D-CA-44], Rep. Burgess, Michael C. [R-TX-26], Rep. Napolitano, Grace F. [D-CA-32], Rep. Cleaver, Emanuel [D-MO-5], Rep. Aguilar, Pete [D-CA-33], Rep. Castor, Kathy [D-FL-14], Rep. Kuster, Ann M. [D-NH-2], Rep. Malinowski, Tom [D-NJ-7], Rep. Raskin, Jamie [D-MD-8], Rep. Evans, Dwight [D-PA-3], Rep. Lowenthal, Alan S. [D-CA-47]
Subjects
Healthcare
Source updated
5 December 2025
Summary
Cancer Drug Parity Act of 20 21 This bill requires group health plans that cover anticancer medications administered by a health care provider to provide no less favorable cost sharing for patient-administered anticancer medications. This requirement applies to medications that are (1) approved by the Food and Drug Administration; (2) medically necessary for the cancer treatment; and (3) clinically appropriate in terms of type, frequency, extent site, and duration. To comply with this requirement, plans may not, with respect to anticancer medications (1) change or replace benefits to increase out-of-pocket costs, (2) reclassify benefits to increase costs, or (3) apply more restrictive limitations to orally administered medications than to intravenously administered or injected medications.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
9 July 2021
Introduced
Referred to the House Committee on Education and Labor.
Source: IntroReferral
9 July 2021
Introduced
Introduced in House
Source: IntroReferral
9 July 2021
Introduced
Introduced in House
Source: IntroReferral
Votes
No vote records are attached yet.
Versions
- Introduced in House · 9 July 2021 · Download file
Documents
3 official files
Introduced in House (text)
This file cannot be previewed here. Use View or Download.
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House (text)
Introduced in House · EN · 9 July 2021
Introduced in House (PDF)
Introduced in House · EN · 9 July 2021
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House
summary · EN · 9 July 2021
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Sponsors
- Rep. Higgins, Brian [D-NY-26] · D · Sponsor
- Rep. Guthrie, Brett [R-KY-2] · R · Sponsor
- Rep. Matsui, Doris O. [D-CA-7] · D · Sponsor
- Rep. Bilirakis, Gus M. [R-FL-12] · R · Sponsor
- Rep. Morelle, Joseph D. [D-NY-25] · D · Sponsor
- Rep. Grothman, Glenn [R-WI-6] · R · Sponsor
- Rep. Case, Ed [D-HI-1] · D · Cosponsor
- Rep. Wild, Susan [D-PA-7] · D · Cosponsor
- Rep. McBath, Lucy [D-GA-6] · D · Cosponsor
- Rep. Clarke, Yvette D. [D-NY-9] · D · Cosponsor
- Rep. Panetta, Jimmy [D-CA-19] · D · Cosponsor
- Rep. Maloney, Carolyn B. [D-NY-12] · D · Cosponsor
- Rep. Bonamici, Suzanne [D-OR-1] · D · Cosponsor
- Rep. Blumenauer, Earl [D-OR-3] · D · Cosponsor
- Rep. Suozzi, Thomas R. [D-NY-3] · D · Cosponsor
- Rep. Brownley, Julia [D-CA-26] · D · Cosponsor
- Rep. Trone, David J. [D-MD-6] · D · Cosponsor
- Rep. Young, Don [R-AK-At Large] · R · Cosponsor
- Rep. Connolly, Gerald E. [D-VA-11] · D · Cosponsor
- Rep. Pingree, Chellie [D-ME-1] · D · Cosponsor
- Rep. Yarmuth, John A. [D-KY-3] · D · Cosponsor
- Rep. Fitzpatrick, Brian K. [R-PA-1] · R · Cosponsor
- Rep. Davis, Rodney [R-IL-13] · R · Cosponsor
- Colin Allred · D · Cosponsor
- Rep. Wittman, Robert J. [R-VA-1] · R · Cosponsor
- Rep. Bost, Mike [R-IL-12] · R · Cosponsor
- Rep. Barragán, Nanette Diaz [D-CA-44] · D · Cosponsor
- Rep. Burgess, Michael C. [R-TX-26] · R · Cosponsor
- Rep. Napolitano, Grace F. [D-CA-32] · D · Cosponsor
- Rep. Cleaver, Emanuel [D-MO-5] · D · Cosponsor
- Rep. Aguilar, Pete [D-CA-33] · D · Cosponsor
- Rep. Castor, Kathy [D-FL-14] · D · Cosponsor
- Rep. Kuster, Ann M. [D-NH-2] · D · Cosponsor
- Rep. Malinowski, Tom [D-NJ-7] · D · Cosponsor
- Rep. Raskin, Jamie [D-MD-8] · D · Cosponsor
- Rep. Evans, Dwight [D-PA-3] · D · Cosponsor
- Rep. Lowenthal, Alan S. [D-CA-47] · D · Cosponsor
- · hsed00 · Standing
Related records
- related to ← Cancer Drug Parity Act of 2021
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/117th-congress/house-bill/4385
- Open data entity: https://api.congress.gov/v3/bill/117/hr/4385
- us · 117-hr-4385 · source updated 5 December 2025